Hangzhou Alltest Biotech Co., Ltd.

¥45.91As of Sun 8 Nov 2026, 12:00 UTC
SSE:688606Healthcare
Country China
PE (Fwd) •••
TSR 6Y CAGR (7.53%)
Div yield 4.36%
ROE 2.95%
Medical Instruments & Supplies
Beta (5Y) 0.23
PE TTM 31.29
TSR TTM (31.83%)
Mkt cap ¥3.480B
ROIC 5.98%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥47
1.66%
(59.49%)
Hold 4|4|5|3|0
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.55
0.56
0.61
0.64
(6.65%)
(8.58%)
3.14%
10.63%
Revenue¥M
201.0
207.8
210.7
217.2
5.30%
10.67%
11.63%
9.75%
Peers (US$521.7M)
Cap (US$)
PE
522.3M
16.78x
Capital
TTM
5Y
10Y
Leveragex
0.775
0.320
0.347
EBIT/Intx
0.647
0.584
0.515
Own earn%
159.44
(31.04)
(37.10)
Sh yield%
36.48
17.83
14.61
Owners
Insiders/Inst%
9.19
83.43
Short interest%
1.96
SBC / revenue%
5.20
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
15–20
$1 testx
—
Incr. ROIC%
9